Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
More emphasis should be given on investing healthcare resources towards prevention of diseases rather than only focusing on diagnostic and therapeutic options
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Subscribe To Our Newsletter & Stay Updated
